Gliomagenesis: genetic alterations and mouse models (original) (raw)

• Kleihues, P. & Cavenee, W. Pathology and genetics of tumors of the nervous system. (IARC Press, Lyon, 2000). An excellent overview of the molecular and histological characteristics of brain tumours.
• Russel, D. S. & Rubenstein, L. J. Pathology of tumors of the nervous system. (Williams & Wilkins, Baltimore, 1989).Classic in-depth text on tumour pathology in the central nervous system.
• Scherer, H. J. Structural development in gliomas. Am. J. Cancer 34 , 333–351 (1938).
  Google Scholar
• Jensen, R. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg. Neurol. 49, 189– 195 (1998).
  Article CAS PubMed Google Scholar
• Uhm, J. H., Dooley, N. P., Villemure, J. G. & Yong, V. W. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can. J. Neurol. Sci. 24, 3–15 (1997).
  Article CAS PubMed Google Scholar
• Gage, F. H. Mammalian neural stem cells. Science 287, 1433–1438 (2000). Review of cell lineage specification in the central nervous system during development and in adulthood.
  Article CAS PubMed Google Scholar
• Lee, J. C., Mayer-Proschel, M. & Rao, M. S. Gliogenesis in the central nervous system. Glia 30, 105–121 ( 2000).
  Article CAS PubMed Google Scholar
• Mi, H. & Barres, B. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J. Neurosci. 19, 1049–1061 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Cameron, H. A., Hazel, T. G. & McKay, R. D. Regulation of neurogenesis by growth factors and transmitters. J. Neurobiol. 36, 287– 309 (1998).
  Article CAS PubMed Google Scholar
• McKinnon, R. D., Matsui, T., Dubois-Dalcq, M. & Aaronson, S. A. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5, 603–614 ( 1990).
  Article CAS PubMed Google Scholar
• Mayer, M., Bogler, O. & Nobel, M. The inhibition of oligodendrocytic differentiation of O2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes. Glia 8, 12– 19 (1993).
  Article CAS PubMed Google Scholar
• Bogler, O., Wren, D., Barnett, S., Land, H. & Nobel, M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type 2 astrocyte (O2A) progenitor cells. Proc. Natl Acad. Sci. USA 87, 6368 –6372 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Mayer, M., Bhakoo, K. & Nobel, M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120, 143– 153 (1994).
  CAS PubMed Google Scholar
• Rajan, P. & McKay, R. D. Multiple routes to astrocytic differentiation in the CNS. J. Neurosci. 18, 3620– 3629 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Nobel, M. & Mayer-Proschel, M. Growth factors, glia and gliomas. J. Neurooncol. 35, 193– 209 (1997).Review of the connections between glial cell differentiation and gliomagenesis.
  Article Google Scholar
• Takahashi, J. et al. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76, 792–798 (1992).
  Article CAS PubMed Google Scholar
• Ekstrand, A. J. et al. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51, 2164–2172 (1991).
  CAS PubMed Google Scholar
• Weis, J. et al. CNTF and its receptor subunits in human gliomas. J. Neurooncol. 44, 243–253 (1999).
  Article CAS PubMed Google Scholar
• Guha, A., Dashner, K., Black, P. M., Wagner, J. A. & Stiles, C. D. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int. J. Cancer 60, 168– 173 (1995).
  Article CAS PubMed Google Scholar
• Wong, A. J. et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl Acad. Sci. USA 89 , 2965–2969 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225– 236 (1995).
  Article CAS PubMed Google Scholar
• Martin-Blanco, E. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 22, 637–645 ( 2000).
  Article CAS PubMed Google Scholar
• Xu, G. F. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63, 835–841 ( 1990).
  Article CAS PubMed Google Scholar
• Guha, A., Feldkamp, M. M., Lau, N., Boss, G. & Pawson, A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15, 2755– 2765 (1997).
  Article CAS PubMed Google Scholar
• Jiang, B. H., Aoki, M., Zheng, J. Z., Li, J. & Vogt, P. K. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl Acad. Sci. USA 96, 2077–2081 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Thomas, G. & Hall, M. N. TOR signaling and control of cell growth. Curr. Opin. Cell Biol. 9, 782– 787 (1997).
  Article CAS PubMed Google Scholar
• Fujisawa, H. et al. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am. J. Pathol. 155, 387–394 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sano, T. et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res. 59, 1820–1824 (1999).
  CAS PubMed Google Scholar
• Holland, E. C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genet. 12, 55–57 (2000).This study demonstrated the cooperation between the Ras and Akt signalling pathways in the formation of GBMs in a mouse model. PubMed
  Article Google Scholar
• Ichimura, K., Schmidt, E. E., Goike, H. M. & Collins, V. P. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13, 1065–1072 ( 1996).A large series of gliomas were analysed for mutations in this study, illustrating the importance of cell-cycle arrest pathways in GBM formation.
  CAS PubMed Google Scholar
• Jen, J. et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54, 6353–6358 (1994).
  CAS PubMed Google Scholar
• Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
  Article CAS PubMed Google Scholar
• Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19Arf. Cell 91, 649–659 (1993). PubMed
  Article Google Scholar
• Pomerantz, J. et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 . Cell 92, 713–723 (1998).
  Article CAS PubMed Google Scholar
• Haber, D. A. Splicing into senescence: the curious case of p16 and p19ARF. Cell 91, 555–558 ( 1997).
  Article CAS PubMed Google Scholar
• Sherr, C. J. & Weber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94–99 (2000).
  Article CAS PubMed Google Scholar
• Liggett, W. H. Jr & Sidransky, D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16, 1197–1206 ( 1998).
  Article CAS PubMed Google Scholar
• Fulci, G. et al. p53 gene mutation and _ink4a_-arf deletion appear to be two mutually exclusive events in human glioblastoma. Oncogene 19, 3816–3822 ( 2000).
  Article CAS PubMed Google Scholar
• Louis, D. N. The p53 gene and protein in human brain tumors. J. Neuropath. Exp. Neurol. 53, 11–21 ( 1994).
  Article CAS PubMed Google Scholar
• Costello, J. F. et al. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57, 1250–1254 ( 1997).
  CAS PubMed Google Scholar
• He, J., Reifenberger, G., Liu, L., Collins, V. P. & James, C. D. Analysis of glioma cell lines for amplification and overexpression of MDM2. Genes Chromosomes Cancer 11, 91–96 ( 1994).
  Article CAS PubMed Google Scholar
• von Deimling, A. et al. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Path. 3, 19– 23 (1993).
  Article CAS Google Scholar
• van Meyel, D. J. et al. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J. Natl Cancer Inst. 86, 1011–1017 ( 1994).
  Article CAS PubMed Google Scholar
• Marutani, M. et al. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastomamultiforme. Cancer Res. 59, 4765–4769 (1999).
  CAS PubMed Google Scholar
• Watanabe, K. et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 6, 217–223 (1996).
  Article CAS PubMed Google Scholar
• Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 257, 1943–1947 (1997). PubMed
  Article Google Scholar
• Teng, D. H. et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221– 5225 (1997).
  CAS PubMed Google Scholar
• Paramio, J. M., Segrelles, C., Casanova, M. L. & Jorcano, J. L. Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation . J. Biol. Chem. 275, 41219– 41226 (2000).
  Article CAS PubMed Google Scholar
• Hass, R. Retrodifferentiation and cell death. Crit. Rev. Oncol. 5, 359–371 (1994). PubMed
  Article CAS Google Scholar
• Hoshimaru, M., Ray, J., Sah, D. W. & Gage, F. H. Dedifferentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc. Natl Acad. Sci. USA 93, 1518–1523 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Prados, M. D. & Levin, V. Biology and treatment of malignant glioma. Semin. Oncol. 27, S1– S10 (2000).
  Google Scholar
• Castro, M. G. et al. Gene therapy strategies for intracranial tumours: glioma and pituitary adenomas. Histol. Histopathol. 15, 1233–1252 (2000).
  CAS PubMed Google Scholar
• Pollack, I. F., Okada, H. & Chambers, W. H. Exploitation of immune mechanisms in the treatment of central nervous system cancer. Semin. Pediatr. Neurol. 7, 131–143 (2000).
  Article CAS PubMed Google Scholar
• Finkelstein, S. D. et al. Histological characteristics and expression of acidic and basic fibroblast growth factor genes in intracerebral xenogeneic transplants of human glioma cells. Neurosurgery 34, 136–143 (1994).
  CAS PubMed Google Scholar
• Aguzzi, A., Brandner, S., Isenmann, S., Steoinbach, J. P. & Sure, U. Transgenic and gene disrupution techniques in the study of neurocarcinogenesis. Glia 15, 348–364 (1995).
  Article CAS PubMed Google Scholar
• Macleod, K. F. & Jacks, T. Insights into cancer from transgenic mouse models. J. Pathol. 187, 43–60 (1999).A review of the uses of germline-modification strategies in mice for studying human cancers.
  Article CAS PubMed Google Scholar
• Fisher, G. H. et al. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 18, 5253–5260 (1999). A review of the somatic-cell gene-transfer approach to modelling cancer in mice.
  Article CAS PubMed Google Scholar
• Holland, E. C. et al. Astrocytes can give rise to oligodendrocytomas and astrocytomas after transfer of middle T antigen in mice. Am. J. Pathol. 157, 1031–1037 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468–472 ( 1999).
  Article CAS PubMed Google Scholar
• Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199–207 (1999).
  Article CAS PubMed Google Scholar
• Pelengaris, S., Littlewood, T., Khan, M., Elia, G. & Evan, G. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3 , 565–577 (1999).
  Article CAS PubMed Google Scholar
• Wessenberger, J. et al. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene 14, 2005–2013 (1997).
  Article Google Scholar
• Uhrbom, L., Hesselager, G., Nister, M. & Westermark, B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 58, 5275–5279 (1998).
  CAS PubMed Google Scholar
• Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E. & Jacks, T. Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nature Genet. 26, 109–113 (2000).This paper reported cooperation between signalling pathways and cell-cycle arrest pathways in the formation of gliomas in a mouse model.
  Article CAS PubMed Google Scholar
• Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27– 37 (1996).
  Article CAS PubMed Google Scholar
• Holland, E. C., Hively, W.P., Gallo, V. & Varmus, H. E. Overexpression of cdk4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes, modeling mutations in the G1 arrest pathway in human gliomas . Genes Dev. 12, 3644–3649 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H. & Sherr, C. J. Tumor spectrum in ARF-deficient mice. Cancer Res. 59, 2217– 2222 (1999).
  CAS PubMed Google Scholar
• Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
  Article CAS PubMed Google Scholar
• Yahanda, A. M., Bruner, J. M., Donehower, L. A. & Morrison, R. S. Astrocytes derived from _p53_-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol. Cell. Biol. 15, 4249–5259 ( 1995).
  Article CAS PubMed PubMed Central Google Scholar
• Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
  Article CAS PubMed Google Scholar
• Wiliams, B. O. et al. Extensive contribution of _Rb_-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251–4259 ( 1994).
  Article Google Scholar
• Holland, E. C., Hively, W. P., DePinho, R. A. & Aarmus, H. E. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell cycle arrest pathways to induce gliomas in mice. Genes Dev. 12, 3675–3685 ( 1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lal, A. et al. A public database for gene expression in human cancers. Cancer Res. 59, 5403–5407 (1999).
  CAS PubMed Google Scholar